Literature DB >> 20690857

Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population.

Jonas Lindh1, Martin Tondel, Bodil Persson, Magnus Vrethem.   

Abstract

PURPOSE: To evaluate the quality of life (QOL) in patients with cryptogenic polyneuropathy.
METHOD: Two validated instruments (SF-36 and EQ-5D) were sent to 86 patients with a 72% response rate (44 men, 18 women). As reference, 2721 individuals (1292 men, 1429 women; 59% response rate) from the general population responded to the same QOL instruments.
RESULTS: Compared to the general population, QOL was significantly more affected in patients with polyneuropathy concerning motor functions, with 42% of the patients reporting problems with walking, 7% having difficulties with washing and dressing, and 31% having problems with usual activities (work, study, household work, and family or leisure activities). The EQ-5D results showed that 85% of the patients were suffering from pain compared to 56% of the general population. Mental health was preserved among patients with polyneuropathy. Mobility was declining with increasing age in patients, but was not affected by disease duration.
CONCLUSIONS: Our study showed that patients with cryptogenic polyneuropathy have a lower QOL compared to the general population, although mental health scores did not differ between the groups. This information may be helpful when explaining the disease and its impact on newly diagnosed patients.
© 2011 Informa UK, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20690857     DOI: 10.3109/09638288.2010.505996

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  6 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

Review 2.  Chronic idiopathic axonal polyneuropathy: a systematic review.

Authors:  Panagiotis Zis; Ptolemaios Georgios Sarrigiannis; Dasappaiah Ganesh Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  J Neurol       Date:  2016-03-09       Impact factor: 4.849

3.  Chronic idiopathic axonal polyneuropathy: Prevalence of pain and impact on quality of life.

Authors:  Panagiotis Zis; Ptolemaios G Sarrigiannis; Dasappaiah G Rao; Channa Hewamadduma; Marios Hadjivassiliou
Journal:  Brain Behav       Date:  2018-11-25       Impact factor: 2.708

Review 4.  Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects.

Authors:  Brigitte A Brouwer; Bianca T A de Greef; Janneke G J Hoeijmakers; Margot Geerts; Maarten van Kleef; Ingemar S J Merkies; Catharina G Faber
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

5.  Idiopathic small fiber neuropathy: phenotype, etiologies, and the search for fabry disease.

Authors:  Kristin Samuelsson; Konstantinos Kostulas; Magnus Vrethem; Arndt Rolfs; Rayomand Press
Journal:  J Clin Neurol       Date:  2014-04-23       Impact factor: 3.077

Review 6.  Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.

Authors:  Kristin Samuelsson; Rayomand Press
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.